Versigent Financials - Benzinga

Versigent PLC

VGNTNYSE

Trade with Public

Trade with Public

$46.73

1.513.34%

In chiusura: Sep 25, 5:00 PM EST

$44.67

-2.06-4.41%

Post-mercato: Sep 25, 1:39 AM EST

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

Versigent Financials

Versigent (VGNT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Versigent Q2 EPS $1.92 Beats $1.35 Estimate, Sales $2.444B Beat $2.313B Estimate

Versigent (NYSE:VGNT) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.35 by 42.22 percent. The company reported quarterly sales of $2.444 billion which beat the analyst

Benzinga Newsdesk

PRO
CORRECTION: Versigent Raises FY2026 Sales Guidance from $9.100B-$9.400B to $9.400B-$9.600B vs $9.286B Est

Versigent (NYSE:VGNT) raises FY2026 sales outlook from $9.100 billion-$9.400 billion to $9.400 billion-$9.600 billion vs $9.286 billion estimate.

Benzinga Newsdesk

PRO
Versigent Sees FY2026 Sales $9.100B-$9.400B

Versigent (NYSE:VGNT) sees FY2026 sales of $9.100 billion-$9.400 billion.

Benzinga Newsdesk

PRO
Versigent Q1 Sales $2.212B Up From $2.024B YoY

Versigent (NYSE:VGNT) reported $2.212 billion in sales this quarter. This is a 9.29 percent increase over sales of $2.024 billion the same period last year.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved